Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Mama Bear who wrote (2217)	2/3/1998 5:16:00 PM
From: Dauntless	Read Replies (2) \| Respond to of 7041

No Barb, I didn't bring it up I was responding to Cacaito's post to me - and furthermore I don't give a damn about how it played out on the Solv Ex thread. For those on this thread who are unfamiliar with the Solv Ex story, click on the following link and be transported to Asholioland to read about this gem. asensio.com A very interesting mess but very different, in fundamental ways, from the Zonagen story - You wrote - <<I heard the same garbage on that thread>> Well, IMO, it's not garbage & here's some of the reasons why.... - Zonagen founded through a technology transfer program from the Baylor College of Medicine. - Baylor College of Medicine initially a major stockholder with board representation. - Initial investors were some of the best known venture capital firms including Ross Perot's - There were no "convicted securities fraud felon" (Asensio's term) among the founders - Zonagen is developing a pharmaceutical - not a coal mine - Zonagen's facilities are in a well known, suburban area - not a remote, inaccessible part of Canada - The development of Zonagen's products are conducted under the regulations issued by the FDA - not too easy to fool - Zonagen's developments to date have been scrutinized by four major pharmaceutical companies - especially by SGP - etc., etc., etc. Maybe it's me, but I just don't see too much similarity - or too much reason to worry about fraud in Zonagen's case. There's regulatory risk (always), there's patent risk (always - until it issues), market risk - maybe some others - but not fraud.